Encontrados 2 documentos, a visualizar página 1 de 1
Mineral and Bone Disease (MBD) on a Kidney Transplant Patient
Birne, R; Adragão, T; Ferreira, A; Dickson, J; Silva, R; Casqueiro, A; Oliveira, R; Martins, AR; Torres, J; Matias, P; Branco, P; Jorge, C; Weigert, AA 50-year-old post-menopausal recipient of a kidney allograft with bone pain, osteoporosis, persistent hypercalcaemia and elevated parathormone (PTH) levels, despite a satisfactory graft function, was treated with bisphosphonates and cinacalcet starting, respectively, 5 and 6 months after renal transplantation (RT). Sixteen months after treatment, there was improvement of bone mineral density (BMD) measured by ...
Achieving K/DOQI Targets with Cinacalcet in Dialysis Patients with Secondary Hy...
Macário, F; Frazão, JM; Ferreira, A; Weigert, A; Mota, M; Machado, D; Birne, R; Neto, R; Baldaia Moreira, A; Soares, C; Ribeiro, S; Mendes, T; Alves, RSecondary hyperparathyroidism is a common complication of chronic kidney disease. The elevated serum intact parathyroid hormone, phosphorus, calcium and calcium x phosphorus product have been independently associated with an increased relative risk of mortality. The standard therapy for secondary hyperparathyroidism, including active vitamin D analogues and phosphate binders, is often insufficient to allow pati...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||